Effect of 2,3,5,4′-tetrahydroxystttbene-2-o-β-D-glucoside on hippocampal genes expression in mimetic-dementia mice induced by D-galactose

Chinese Journal of Pharmacology and Toxicology

Volumn 19, Issue 1, 2005, Pages 24-28

  Xie, Wen Jie ^a   Li, Lin ^a   Wei, Hai Fens ^a   Chu, Jin ^a   Ye, Cui Fei ^a   Zhang, Lan ^a   Li, Ya Li ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

2,3,5,4 tetrahydroxystilbene 2 o d glucoside; Alzheimer disease; D galactose; Gene expression; Hippocampus

Indexed keywords

2,3,5,4' TETRAHYDROXYSTILBENE 2 O BETA DEXTRO GLUCOSIDE; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; GALACTOSE; GLUCOSIDE; GLYCOGEN PHOSPHORYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MITOCHONDRIAL PROTEIN; POLYPEPTIDE; PYRUVATE DEHYDROGENASE; RNA; SERINE PROTEINASE INHIBITOR; STILBENE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG MECHANISM; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME; HIPPOCAMPUS; INFLAMMATION; LEARNING; MAZE TEST; MEMORY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE;

ANIMALIA;

EID: 14744297390     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chen Y, Wang M, Rosen RT, Ho CT. 2, 2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygomem multiflorum Thunb[J]. J Agric Food Chem, 1999, 47(6):2226-2228.
2. Chu J, Ye CF, Li L. Effects of stilbene glycoside on learning and memory function and free radicals metabolism in dementia model mice[J]. Chin J Rehabil Theory Pract, 2003, 9(11):643-645.
3. Li WB, Wei F, Fan M, Zhang JL, Zhang BL, Ma XC, et al. Mimetic brain aging effect induced by D-galactose in mice[J]. Chin J Pharmacol Toxicol, 1995, 9(2):93-95.
4. Levine S, Payan H. Effects of ischemia and other procedures on the brain and retina of the gerbil (Meriones imguiculatus)[J]. Exp Neurol, 1966, 16(3):255-262.
5. Lehrach HD. RNA molecular weight determinations by gel electrophoresis under denaturing conditions[A]. In: Sambrook J, Fritsch EF, Maniatis T, ed. Molecular Cloning [M]. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989. 364-367.
6. Gsell W, Strein I, Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared[J]. J Neural Transm Suppl, 1995, 17:73-101.
7. Shen SL. Pathophysiological function of β-amyloid[A]. In: Shen SL, eds. Alzheimer's Diseases: From Molecular Biology To Clinic [M]. Beijing: Scientific and Technological Documentation Publishing House, 1998. 243-245.
8. Butterfield DA, Drake J, Pocerruch C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide[J]. Trends Mol Med, 2001, 7(12):548-554.
9. Mrak RE, Griffin WS. Interleukin-1 and the immunogenetics of Alzheimer disease[J]. J Neuropathol Exp Neurol, 2000, 59(6):471-476.
10. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signalingt[J]. J Neurosci Res, 2002, 70(3): 462-473.
11. Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease[J]. Curr Med Chem, 2001, 8(7):721-738.
12. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer' s disease[J]. J Mol Neurosci, 2001, 17(2):101-118.
13. Franceschi C, Valensin S, Lescai F, Olivieri F, Licastro F, Grimaldi LM, et al. Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype[J]. Aging (Milano), 2001, 13(3):163-170.